SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C.  20549


                              FORM 10-K
(Mark One)

[X]         ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934

             For the fiscal year ended December 31, 2011


[  ]        TRANSITION REPORT PURSUANT TO SECTION 13 OR
            15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
            For the transition period from          to

                   Commission file number 000-54541

                 AMERICAN LASER HEALTHCARE CORPORATION
          (Exact name of registrant as specified in its charter)

                    BIOLASER TECHNOLOGY INC.
                  (Former Name of Registrant)

            Delaware                           54-3417732
    (State or other jurisdiction of           (I.R.S. Employer
     incorporation or organization)          Identification No.)

            215 Apolena Avenue, Newport Beach, CA 92662
        (Address of principal executive offices)  (zip code)


Registrant's telephone number, including area code:    202/387-5400

    Securities registered pursuant to Section 12(b) of the Act:  None

   Securities registered pursuant to Section 12(g) of the Exchange Act:

             Common Stock, $.0001 par value per share
                    (Title of class)


Indicate by check mark if the registrant is a well-known seasoned issuer,
as defined in Rule 405 of the Securities Act
						[  ] Yes   [ X ] No

Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the Act.

						[  ] Yes   [ X ] No

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

						[ X ] Yes   [   ] No

Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Website, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (Section 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit
and post such files).

						[ X ] Yes   [   ] No

Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K (Section 229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant's
knowledge, in definitive proxy or information statements incorporated by
reference in Part III of this Form 10-K or any amendment to this Form
10-K.
						[ X ] Yes   [  ] No


Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company.  See the definitions of "large accelerated
filer", "accelerated filer", "non-accelerated filer", and "smaller
reporting company" in Rule 12b-2 of the Exchange Act.

Large Accelerated filer  [  ]       Accelerated filer         [   ]
Non-accelerated filer    [  ]       Smaller reporting company [ X ]
  (do not check if smaller reporting company)


Indicate by check mark whether the registrant is a shell company
   (as defined in Rule 12b-2 of the Exchange Act).

						[ X ] Yes   [  ] No

State the aggregate market value of the voting and non-voting common
equity held by non-affiliates computed by reference to the price at
which the common equity was last sold, or the average bid and asked
price of such common equity, as of the last business day of the
registrant's most recently completed second fiscal quarter.

							    $ 0

Indicate the number of shares outstanding of each of the registrant's
classes of common stock as of the latest practicable date.

       Class                                  Outstanding at
                                            December 31, 2011

Common Stock, par value $0.0001                 20,000,000

Documents incorporated by reference:            None


                               PART I

Item 1.  Business


   American Laser Healthcare Corporation (formerly Amberwood Acquisition
Corporation (the "Company") was incorporated on September 21, 2011 under
the laws of the State of Delaware to engage in any lawful corporate
undertaking, including, but not limited to, selected mergers and
acquisitions. The Company has been in the developmental stage since
inception and its operations to date have been limited to issuing shares
to its original shareholders and filing a registration statement. The
Company has been formed to provide a method for a foreign or domestic
private company to become a reporting company with a class of securities
registered under the Securities Exchange Act of 1934.

    On February 23, 2012, the shareholders of the Corporation and the
Board of Directors unanimously approved the change of the Company's
name to BioLaser Technology Inc. and filed such change with the
State of Delaware and filed a Form 8-K with the Securities and
Exchange Commission.

    On March 16, 2012, the shareholders of the Corporation and the Board
of Directors unanimously approved the change of the Company's name to
American Laser Healthcare Corporation and filed such change with the State
of Delaware and filed a Form 8-K with the Securities and Exchange
Commission.

     The Company registered its common stock on a Form 10
registration statement filed pursuant to the Securities Exchange
Act of 1934 (the "Exchange Act") and Rule 12(g) thereof.  The
Company files with the Securities and Exchange Commission periodic
and current reports under Rule 13(a) of the Exchange Act, including
quarterly reports on Form 10-Q and annual reports Form 10-K.

     For the period of time covered by this Report, the Company had no
employees and two officers, directors and shareholders.

     The president of the Company was the president, director and
shareholder of Tiber Creek Corporation.  Tiber Creek Corporation assists
companies in becoming public reporting companies and with introductions
to the financial community.  To become a public company, Tiber Creek
Corporation may recommend that a company file a registration statement,
most likely on Form S-1, or alternatively that a company first effect a
business combination with the Company and then subsequently file a
registration statement.  A company may choose to effect a business
combination with the Company before filing a registration statement as
such method may be an effective way to obtain exposure to the brokerage
community.

     A combination will normally take the form of a merger, stock-for-stock
exchange or stock-for-assets exchange.  In most instances the target
company will wish to structure the business combination to be within the
definition of  a tax-free reorganization under Section 351 or Section 368
of the Internal Revenue Code of 1986, as amended.

     As of December 31, 2011, the Company had not generated revenues
and had no income or cash flows from operations since inception.  At
December 31, 2011, the Company had sustained net loss of $1,343 and had
accumulated a deficit of $1,343.

     The Company's independent auditors have issued a report raising
substantial doubt about the Company's ability to continue as a going
concern.  At present, the Company has no operations and the continuation
of the Company as a going concern is dependent upon financial support from
its stockholders, its ability to obtain necessary equity financing to
continue operations and/or to successfully locate and negotiate with a
business entity for the combination of that target company with the Company.

     Until the change in control of the Company Tiber Creek Corporation
paid all expenses incurred by the Company without repayment. There is
no written agreement between Tiber Creek Corporation and the Company.
Because of the absence of any on-going operations, these expenses are
anticipated to be relatively low.

   Subsequent to the period of time covered by this Report, on March 27,
2012, the following events occurred which resulted in a change of control
of the Company:

	1.  The Company redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001
per share for an aggregate redemption price of $1,950.

	2.   The then current officers and directors resigned.

	3.   New officers and directors were appointed and elected.

	On March 28, 2011 the Company issued 1,000,000 shares of its
common stock.

	Since the change in control the Company intends to develop a
medical device product development business coupled with a healthcare
service business that provides a protocol and pathway for the adoption
and implementation of Low Level Light Therapy (LLLT). The Company
anticipates that it will submit an offer to purchase the assets of a
private LLLT company having an approved device and methodology patent,
FDA clearance and insurance reimbursement code approvals. If successful,
the Company intends to apply for additional United States and international
patents, and broader FDA clearances and reimbursement codes.  No agreement
has been reached and no contracts executed.

    The Company has filed a Form 8-K reporting the change in control.

    There is no assurance that the Company will ever be profitable.

Item 2.  Properties

     The Company has no properties and at this time has no
agreements to acquire any properties.  During period covered by this
Report, the Company used the offices of Tiber Creek Corporation at no
cost to the Company.


Item 3.  Legal Proceedings

     There is no litigation pending or threatened by or against the
Company.


Item 4.  Mine Safety Disclosures.

      Not applicable.


                              PART II

Item 5.  Market for Registrant's Common Equity, Related Stockholder
	 Matters and Issuer Purchases of Equity Securities

      There is currently no public market for the Company's securities.

     Following a business combination, a target company will normally
wish to cause the Company's common stock to trade in one or more United
States securities markets.  The target company may elect to take the
steps required for such admission to quotation following the business
combination or at some later time.

     At such time as it qualifies, the Company may choose to apply for
quotation of its securities on the OTC Bulletin Board.

     The OTC Bulletin Board is a dealer-driven quotation service.
Unlike the Nasdaq Stock Market, companies cannot directly apply to be
quoted on the OTC Bulletin Board, only market makers can initiate
quotes, and quoted companies do not have to meet any quantitative
financial requirements.  Any equity security of a reporting company not
listed on the Nasdaq Stock Market or on a national securities exchange
is eligible.

     As such time as it qualifies, the Company may choose to apply for
quotation of its securities on the Nasdaq Capital Market.

     In general there is greatest liquidity for traded securities on
the Nasdaq Capital Market and less on the OTC Bulletin Board.  It is
not possible to predict where, if at all, the securities of the Company
will be traded following a business combination.

     During period covered by this Report and since inception, the
Company has sold securities which were not registered as follows:

                                            NUMBER OF
DATE                     NAME               SHARES       CONSIDERATION

September 21, 2011    Tiber Creek 	     10,000,000    $1,000
		    Corporation (1)       (of which 9,750,000 redeemed)

September 21, 2011  MB Americus LLC (2)      10,000,000	   $1,000
                                          (of which 9,750,000 redeemed)

     Subsequent to the period covered by this Report, the Company issued
1,000,000 shares of its common stock as reported in the Form 8-K filed
by it.

(1)  James M. Cassidy, was the president and a director of the Company,
and is the sole shareholder and director of Tiber Creek Corporation,
a Delaware corporation, and Mr. Cassidy may be deemed to be the
beneficial owner of the shares of stock owned by Tiber Creek Corporation.

(2)   James McKillop is the sole principal of MB Americus LLC, a
California limited liability corporation.  Mr. McKillop is deemed to
be the beneficial owner of the shares of stock owned by MB Americus LLC.


Item 6.  Selected Financial Data.

	There is no selected financial data required to be filed for
a smaller reporting company.


Item 7.  Management's Discussion and Analysis of Financial Condition
	 and Results of Operations

   The Company has no operations nor does it currently engage in any
business activities generating revenues.  The Company's principal
business objective is to achieve a business combination with a target
company.

     As of December 31, 2011, the Company had not generated revenues and
had no income or cash flows from operations since inception.  At December
31, 2011, the Company had sustained net loss of $1,343 and had accumulated
a deficit of $1,343.

    The Company's independent auditors have issued a report raising
substantial doubt about the Company's ability to continue as a going
concern.  At present, the Company has no operations and the continuation
of the Company as a going concern is dependent upon financial support from
its stockholders, its ability to obtain necessary equity financing to
continue operations and/or to successfully locate and negotiate with a
business entity for the combination of that target company with the Company.

     During the period covered by this Report, Tiber Creek Corporation paid
all expenses incurred by the Company until a change in control without
repayment. There is no written agreement between Tiber Creek Corporation
and the Company.  Because of the absence of any on-going operations,
these expenses are anticipated to be relatively low.

     During the period covered by this Report, the president of the Company
was the president, director and shareholder of Tiber Creek Corporation.
Tiber Creek Corporation assists companies in becoming public reporting
companies and with introductions to the financial community.  To become a
public company, Tiber Creek Corporation may recommend that a company file
a registration statement, most likely on Form S-1, or alternatively that
a company first effect a business combination with the Company and then
subsequently file a registration statement.  A company may choose to effect
a business combination with the Company before filing a registration
statement as such method may be an effective way to obtain exposure to
the brokerage community.

     A combination will normally take the form of a merger, stock-for-stock
exchange or stock-for-assets exchange.  In most instances the target
company will wish to structure the business combination to be within the
definition of  a tax-free reorganization under Section 351 or Section 368
of the Internal Revenue Code of 1986, as amended.

     No assurances can be given that the Company will be successful in
locating or negotiating with any target company.

   The most likely target companies are those seeking the perceived
benefits of a reporting corporation.  Such perceived benefits may include
facilitating or improving the terms on which additional equity financing
may be sought, providing liquidity for incentive stock options or similar
benefits to key employees, increasing the opportunity to use securities
for acquisitions, providing liquidity for shareholders and other factors.
Business  opportunities may be available in many different industries and
at various stages of development, all of which will make the task of
comparative investigation and analysis of such business opportunities
difficult and complex.

   The search for a target company will not be restricted to any specific
kind of business entities, but may acquire a venture which is in its
preliminary or development stage, which is already in operation, or in
essentially any stage of its business life.  It is impossible to predict
at this time the status of any business in which the Company may become
engaged, whether such business may need to seek additional capital, may
desire to have its shares publicly traded, or may seek other perceived
advantages which the Company may offer.

   In implementing a structure for a particular business acquisition, the
Company may become a party to a merger, consolidation, reorganization,
joint venture, licensing agreement or other arrangement with another
corporation or entity.  On the consummation of a transaction, it is likely
that the present management and shareholders of the Company will no longer
be in control of the Company.  In addition, it is likely that the officer
and director of the Company will, as part of the terms of the business
combination, resign and be replaced by one or more new officers and
directors.

     It is anticipated that any securities issued in any such
business combination would be issued in reliance upon exemption
from registration under applicable federal and state securities
laws.  In some circumstances, however, as a negotiated element of
its transaction, the Company may agree to register all or a part of
such securities immediately after the transaction is consummated or
at specified times thereafter.  If such registration occurs, it
will be undertaken by the surviving entity after the Company has
entered into an agreement for a business combination or has
consummated a business combination.  The issuance of additional
securities and their potential sale into any trading market which
may develop in the Company's securities may depress the market
value of the Company's securities in the future if such a market
develops, of which there is no assurance.

   While the terms of a business transaction to which the Company may
be a party cannot be predicted, it is expected that the parties to the
business transaction will desire to avoid the creation of a taxable event
and thereby structure the acquisition in a tax-free reorganization under
Sections 351 or 368 of the Internal Revenue Code of 1986, as amended.

   The Company will participate in a business combination only after the
negotiation and execution of appropriate agreements.

   Subsequent to the period of time covered by this Report, on March 27,
2012, the following events occurred which resulted in a change of control
of the Company:

	1.  The Company redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001
per share for an aggregate redemption price of $1,950.

	2.   The then current officers and directors resigned.

	3.   New officers and directors were appointed and elected.

	On March 28, 2011 the Company issued 1,000,000 shares of its
common stock.

	Since the change in control the Company intends to develop a
medical device product development business coupled with a healthcare
service business that provides a protocol and pathway for the adoption
and implementation of Low Level Light Therapy (LLLT). The Company
anticipates that it will submit an offer to purchase the assets of a
private LLLT company having an approved device and methodology patent,
FDA clearance and insurance reimbursement code approvals. If successful,
the Company intends to apply for additional United States and international
patents, and broader FDA clearances and reimbursement codes.  No agreement
has been reached and no contracts executed.

    The Company has filed a Form 8-K reporting the change in control.

2011 Year-End Analysis

      The Company has received no income, has had no operations
nor expenses, other than Delaware state fees and accounting fees
as required for incorporation and for the preparation of the
Company's financial statements.

     As of December 31, 2011, the Company had not generated revenues
and had no income or cash flows from operations since inception.  At
December 31, 2011, the Company had sustained net loss of $1,343 and had
accumulated a deficit of $1,343.

Critical Accounting Policies

Adopted

     In January 2010, FASB issued ASU No. 2010-01- Accounting for
Distributions to Shareholders with Components of Stock and Cash. The
amendments in this update clarify that the stock portion of a distribution
to shareholders that allows them to elect to receive cash or stock with a
potential limitation on the total amount of cash that all shareholders can
elect to receive in the aggregate is considered a share issuance that is
reflected in EPS prospectively and is not a stock dividend for purposes of
applying Topics 505 and 260 (Equity and Earnings Per Share). The
amendments in this update are effective now. The adoption of this ASU
did not have a material impact on the COmpany's financial statements.

     In January 2010, FASB issued ASU No. 2010-06   Improving
Disclosures about Fair Value Measurements. This update provides
amendments to Subtopic 820-10 that requires new disclosure as follows:
1) Transfers in and out of Levels 1 and 2.  A reporting entity should
disclose separately the amounts of significant transfers in and out of
Level 1 and Level 2 fair value measurements and describe the reasons for
the transfers.  2)  Activity in Level 3 fair value measurements.  In the
reconciliation for fair value measurements using significant unobservable
inputs (Level 3), a reporting entity should present separately information
about purchases, sales, issuances, and settlements (that is, on a gross
basis rather than as one net number). This update provides amendments to
Subtopic 820-10 that clarifies existing disclosures as follows: 1) Level
of disaggregation. A reporting entity should provide fair value measurement
disclosures for each class of assets and liabilities. A class is often a
subset of assets or liabilities within a line item in the statement of
financial position. A reporting entity needs to use judgment in determining
the appropriate classes of assets and liabilities. 2) Disclosures about
inputs and valuation techniques. A reporting entity should provide
disclosures about the valuation techniques and inputs used to measure
fair value for both recurring and nonrecurring fair value measurements.
Those disclosures are required for fair value measurements that fall in
either Level 2 or Level 3. The new disclosures and clarifications of
existing disclosures are effective now. The adoption of the ASU's did
not have a material impact on the Company's financial statements.

     In December 2010, the FASB issued ASU 2010-29, which contains updated
accounting guidance to clarify the acquisition date that should be
used for reporting pro forma financial information when comparative
financial statements are issued.  This update requires that a company
should disclose revenue and earnings of the combined entity as though
the business combination(s) that occurred during the current year had
occurred as of the beginning of the comparable prior annual reporting
period only.  This update also requires disclosure of the nature and
amount of material, nonrecurring pro forma adjustments. The adoption
of this ASU did not have a material impact on the Company's financial
statements.

     In September 2011, the Financial Accounting Standards Board
("FASB") issued Accounting Standards Update ("ASU") 2011-08,
"Intangibles-Goodwill and Other (Topic 350): Testing Goodwill
Impairment" which is intended to simplify goodwill impairment testing
by permitting the assessment of qualitative factors to determine whether
events and circumstances lead to the conclusion that it is necessary to
perform the traditional two-step impairment test.  Under this update, we
are not required to calculate the fair value of our reporting units unless
we conclude that it is more likely than not (likelihood of more than 50%)
that the carrying value of our reporting units is greater than the fair
value of such units based on our assessment of events and circumstances.
This update is effective for fiscal years beginning after December 15,
2011, with early adoption permitted.  The Company has adopted the
provisions of this update at the beginning of our fourth quarter.
The adoption of this provision did not have a material impact on the
Company's financial statements.



Item 8.  Financial Statements and Supplementary Data

     The financial statements and audit report issued by our independent
registered public accounting firm as of December 31, 2011 and the period
from September 21, 2011 (inception) through December 31, 2011 are
attached hereto.



Item 9.   Changes in and Disagreements with Accountants on
          Accounting and Financial Disclosure

     There were no changes in or disagreements with accountants on
accounting and financial disclosure for the period covered by this
report.

Item 9A.   Controls and Procedures

    Pursuant to Rules adopted by the Securities and Exchange Commission.
the Company carried out an evaluation of the effectiveness of the design
and operation of its disclosure controls and procedures pursuant to
Exchange Act Rules.  This evaluation  was done as of the end of the fiscal
year under the supervision and with the participation of the Company's
principal executive officer who is also the principal financial officer.
There have been no significant changes in internal controls or in other
factors that could significantly affect internal controls subsequent to
the date of the evaluation.  Based upon that evaluation, they believe
that the Company's disclosure controls and procedures are effective in
gathering, analyzing and disclosing information needed to ensure that
the information required to be disclosed by the Company in its periodic
reports is recorded, summarized and processed timely.  The principal
executive officer is directly involved in the day-to-day operations
of the Company.

Management's Report of Internal Control over Financial Reporting

     The Company is responsible for establishing and maintaining
adequate internal control over financial reporting in accordance with
the Rule 13a-15 of the Securities Exchange Act of 1934. The Company's
officer, its president, conducted an evaluation of the effectiveness
of the Company's internal control over financial reporting as of
December 31, 2011, based on the criteria establish in Internal
Control Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treaedway Commission.  Based on this evaluation,
management concluded that the Company's internal control over financial
reporting was effective as of December 31, 2011, based on those criteria.
A control system can provide only reasonably, not absolute, assurance
that the objectives of the control system are met and no evaluation
of controls can provide absolute assurance that all control issues have
been detected.

     Anton & Chia the independent registered public accounting
firm for the Company, has not issued an attestation report on the
effectiveness of the Company's internal control over financial reporting.

Changes in Internal Control Over Financial Reporting

     There have been no changes in the Company's internal controls over
financial reporting  during its fourth fiscal quarter that have materially
affected, or are reasonably likely to materially affect, its internal
control over financial reporting.

Item 9B.  Other Information

     Not applicable.

                             PART III

Item 10.  Directors, Executive Officers, and Corporate Governance;


     As of the period of time covered by this Report, the directors and
Officers of the Company were as follows:

      Name                Age       Positions and Offices Held
     -----------------    -----------
     James Cassidy         76       President, Secretary, Director
     James McKillop	   52       Vice President, Director

Management of the Company

     As of the period of time covered by this Report, the Company had no
full time employees.  James Cassidy and James McKillop were the officers
and directors of the Company and its indirect beneficial shareholders.
Mr. Cassidy, as president of the Company, and Mr. McKillop as vice president,
allocated a limited portion of time to the activities of the Company without
compensation. Potential conflicts may arise with respect to the limited time
commitment by management and the potential demands of the activities of the
Company.

    James Cassidy, Esq., LL.B., LL.M., director, president and secretary
of the Company.  Mr. Cassidy received a Bachelor of Science in Languages
and Linguistics from Georgetown University in 1960, a Bachelor of Laws
from The Catholic University School of Law in 1963, and a Master of Laws
in Taxation from The Georgetown University School of Law in 1968.
From 1963-1964, Mr. Cassidy was law clerk to the Honorable Inzer B. Wyatt
of the United States District Court for the Southern District of New York.
From 1964-1965, Mr. Cassidy was law clerk to the Honorable Wilbur K.
Miller of the United States Court of Appeals for the District of Columbia.
From 1969-1975, Mr. Cassidy was an associate of the law firm of Kieffer &
Moroney and a principal in the law firm of Kieffer & Cassidy,
Washington, D.C. From 1975 to date, Mr. Cassidy has been a principal in the
law firm of Cassidy & Associates, and its predecessors, specializing in
securities law and related corporate and federal taxation matters.
Mr. Cassidy is a member of the bars of the District of Columbia and the
State of New York, and is admitted to practice before the United States
Tax Court and the United States Supreme Court.  The Company believes Mr.
Cassidy to have the business experience necessary to serve as a director
of the Company as it seeks to enter into a business combination.  As a
lawyer involved in business transactions and securities matters, Mr.
Cassidy has  had ample experience in evaluating companies and management,
understanding business plans, assisting in capital raising  and determining
corporate structure and objectives.

    James McKillop, director and vice president of the Company.
Mr. McKillop began his career at Merrill Lynch. Mr. McKillop
has also been involved in financial reporting and did a daily stock market
update for KPCC radio in Pasadena, California.  Mr. McKillop is the founder
of MB Americus LLC which specializes in consulting and public relations.
Mr. McKillop has provided consulting services to Tiber Creek Corporation
for more than five years.  Mr. McKillop has written articles for various
publications on financial matters. He has been a past member of the World
Affairs Council. Mr. McKillop received his Bachelor of Arts in Economics
in 1984 from the University of California at Los Angeles.  With his
background in financial and securities matters, the Company believes Mr.
McKillop to have experience and knowledge that will serve the Company in
seeking, evaluating and determining a suitable target company.

     There are no agreements or understandings for the above-named
officers or directors to resign at the request of another person and the
above-named officers and directors are not acting on behalf of nor will
act at the direction of any other person.

Recent Blank Check Companies

     As of the period of time covered by this Report, James
Cassidy, the president and a director of the Company and
James McKillop, vice president and a director of the Company, were involved
with other existing blank check companies, and in creating additional
similar companies.  The initial business purpose of each of these
companies was or is to engage in a business combination with an
unidentified company or companies and each were or will be classified
as a blank check company until completion of a business combination.

     The information summarizes the blank check companies with
which Mr. Cassidy and/or Mr. McKillop is or has been involved in the
past five years which filed a registration statement on Form 10 or Form
10-SB.  In most instances that a business combination is transacted with
one of these companies, it is required to file a Current Report on Form
8-K describing the transaction.  Reference is made to the Current Report
on Form 8-K filed for any company listed below and for additional
detailed information concerning the business combination entered
into by that company.

     Cabinet Acquisition Corporation: Form 10-SB filed on 8/28/2000,
file  number 0-31398.  Mr. Cassidy was the sole indirect beneficial
shareholder, officer and director of the corporation.  On October 8,
2009, the corporation effected a change in control with the redemption
of stock and the issuance of additional stock and the election of new
directors and appointment of new officers.  Mr. Cassidy retained
500,000 shares and resigned from all offices and as a director.

     Canistel Acquisition Corporation.  Form 10 filed on May 23, 2008,
file number 000-53255.  Mr. Cassidy was the sole officer and director
and Mr. McKillop was an employee of the corporation.  Mr. Cassidy and
Mr. McKillop were the only shareholders and each was indirect beneficial
shareholder.  On December 7, 2010, the corporation filed a form 8-K
noticing the change of control effected on December 3, 2010 with
redemption of 250,000 shares from each of the then two shareholders,
the issuance of additional shares of common stock, the election of new
directors and appointment of new officers.  Mr. Cassidy and Mr. McKillop
each retained 250,000 shares. Mr. Cassidy resigned from all offices and
as a director and Mr. McKillop resigned as an employee.

     Console Acquisition Corporation:  Form 10 filed on May 23, 2008,
file number 000-53257.  Mr. Cassidy was the sole officer and director
and Mr. McKillop was an employee of the corporation.  Mr. Cassidy and
Mr. McKillop were the only shareholders and each was indirect beneficial
shareholder.  On December 22, 2009,  the corporation filed a form 8-K
noticing the change of control effected on December 21, 2009 with the
issuance of additional shares of common stock, the election of new
directors and appointment of new officers.  Mr. Cassidy and Mr. McKillop
each retained 250,000 shares. Mr. Cassidy resigned from all offices and
as a director and Mr. McKillop resigned as an employee.

     Hightower Acquisition Corporation:  Form 10 filed on May 23,
2008, file number 000-53258.  Mr. Cassidy was the sole officer and
director and Mr. McKillop was an employee of the corporation.  Mr.
Cassidy and Mr. McKillop were the only shareholders and each was
indirect beneficial shareholder.  On May 12, 2010, the corporation filed
a form 8-K noticing the change of control effected on December 3, 2010
with redemption of 375,000 shares from each of the then two shareholders,
the issuance of additional shares of common stock, the election of new
directors and appointment of new officers.  Mr. Cassidy and Mr. McKillop
each retained 125,000 shares. Mr. Cassidy resigned from all offices and
as a director and Mr. McKillop resigned as an employee.

     Spinnet Acquisition Corporation:  Form 10 filed on May 23, 2008,
file number 000-53256  Mr. Cassidy was the sole officer and director and
Mr. McKillop was an employee of the corporation.  Mr. Cassidy and Mr.
McKillop were the only shareholders and each was indirect beneficial
shareholder.  On October 5, 2009 the corporation filed a form 8-K noticing
the change of control effected on September 30, 2010 with redemption of
250,000 shares from each of the then two shareholders, the issuance of
additional shares of common stock, the election of new directors and
appointment of new officers.  Mr. Cassidy and Mr. McKillop each retained
250,000 shares. Mr. Cassidy resigned from all offices and as a director
and Mr. McKillop resigned as an employee.

     Greenmark Acquisition Corporation:  Form 10 filed on May 23, 2008,
file number 000-53259.  Mr. Cassidy is the sole officer and director
and Mr. McKillop is an employee of the corporation.  Mr. Cassidy and Mr.
McKillop are the only shareholders and each is the indirect beneficial
shareholder of 500,000 shares.

     Alderwood Acquisition Corporation:  Form 10 filed on October 7,
2010, file number 000-54148.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On July 20, 2011
the corporation filed a Form 8-K noticing the change of control effected
July 15, 2011 with the redemption of 19,800,000 shares of the 20,000,000
shares of outstanding stock, issuance of additional shares of common stock,
the election of new directors and appointment of new officers.  Mr. Cassidy
and Mr. McKillop each beneficially retained 100,000 shares of stock.
Messrs. Cassidy and McKillop each resigned from all offices and as
directors.  The name of the corporation has been changed to SGreenTech
Group Ltd. and subsequently changed to Pixtel Group Ltd.

     Oakwood Acquisition Corporation:  Form 10 filed on October 7,
2010, file number 000-54147.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On December 12,
2011 the corporation filed a Form 8-K noticing the change of control
effected November 30, 2011 with the redemption of 19,500,000 shares of
the 20,000,000 shares of outstanding stock, issuance of additional shares
of common stock, the election of new directors and appointment of new
officers.  Mr. Cassidy and Mr. McKillop each beneficially retained 250,000
shares of stock.  Messrs. Cassidy and McKillop each resigned from all
offices and as directors.  The name of the corporation has been changed to
Bristol Rhace Natural Resource Corporation

     Pinewood Acquisition Corporation:  Form 10 filed on October 7,
2010, file number 000-54146.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On June 1,
2011, Pinewood Acquisition Corporation filed a Form 8-K noticing the
change of control effected May 25, 2011 with the redemption of an
aggregate of 19,500,000 of the then 20,000,000 shares of outstanding
common stock, issuance of additional shares of common stock, the
election of new directors and appointment of new officers.  Mr. Cassidy
and Mr. McKillop each beneficially retained 250,000 shares of stock.
Messrs. Cassidy and McKillop each resigned from all offices and as
directors.  The name of the corporation has been changed to De Yang
International Group Ltd. and subsequently changed to Fun World Media, Inc.

     Sherwood Acquisition Corporation:  Form 10 filed on October 7,
2010, file number 000-54145.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On July 22,
2011, Sherwood Acquisition Corporation filed a Form 8-K noticing the
change of control effected July 20, 2011 with the redemption of an
aggregate of 19,800,000 shares of the then 20,000,000 shares of
of outstanding common stock, issuance of additional shares of common
stock, the election of new directors and appointment of new officers.
Mr. Cassidy and Mr. McKillop each beneficially retained 100,000 shares
of stock.  Messrs. Cassidy and McKillop each resigned from all offices
and as directors.

     Beachwood Acquisition Corporation:  Form 10 filed on June 2,
2011, file number 000-54423.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On August 31,
2011 Beachwood Acquisition Corporation filed a Form 8-K noticing the
change of control effected August 31, 2011 with the redemption of an
aggregate of 18,500,000 shares of the then outstanding 20,000,000 shares
of common stock, issuance of additional shares of common stock, the
election of new directors and appointment of new officers.  Mr.
Cassidy and Mr. McKillop each beneficially retained 750,000 shares
of stock.  Messrs. Cassidy and McKillop each resigned from all offices
and as directors.   The name of the corporation was changed to
BioPharma Manufacturing Solutions Inc.

     Boxwood Acquisition Corporation:  Form 10 filed on June 2,
2011, file number 000-54424.  Mr. Cassidy and Mr. McKillop were both
directors of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders and
each was indirect beneficial owner of 10,000,000 shares.  On November 1,
2011 Boxwood Acquisition Corporation filed a Form 8-K noticing the
change of control effected October 28, 2011 with the redemption of an
aggregate of 19,500,000 shares of the then outstanding 20,000,000 shares
of common stock, issuance of additional shares of common stock, the
election of new directors and appointment of new officers.  Mr.
Cassidy and Mr. McKillop each beneficially retained 250,000 shares
of stock.  Messrs. Cassidy and McKillop each resigned from all ofices
and as directors.   The name of the corporation was changed to
GreenPower International Group, Ltd.

     Cottonwood Acquisition Corporation:  Form 10 filed on June 2,
2011, file number 000-54425.  Mr. Cassidy and Mr. McKillop were the only
shareholders and each was indirect beneficial owner of 10,000,000 shares.
On November 2, 2011 Cottonwood Acquisition Corporation filed a Form 8-K
noticing the change of control effected October 30, 2011 with the redemption
of an aggregate of 19,700,000 shares of the then outstanding 20,000,000
shares of common stock, issuance of additional shares of common stock, the
election of new directors and appointment of new officers.  Mr.
Cassidy and Mr. McKillop each beneficially retained 150,000 shares
of stock.  Messrs. Cassidy and McKillop each resigned from all ofices
and as directors.  The name of the corporation was changed to
Creative Entertainment Holdings, Inc.

     Driftwood Acquisition Corporation:  Form 10 filed on June 2,
2011, file number 000-54426.  Mr. Cassidy and Mr. McKillop were the only
shareholders and each was indirect beneficial owner of 10,000,000 shares
at the time covered by this report.  Subsequent to this period covered
by this report, Driftwood Acquisition Corporation filed a Form 8-K
noticing the change of control effected February 1, 2012 with
the redemption of an aggregate of 19,500,000 shares of the then
outstanding 20,000,000 shares of common stock, issuance of additional
shares of common stock, the election of new directors and appointment
of new officers.  Mr. Cassidy and Mr. McKillop each beneficially
retained 250,000 shares of stock.  Messrs. Cassidy and McKillop each
resigned from all ofices and as directors.  The name of the corporation
was changed to Pivotal Group, Inc.

     Moosewood Acquisition Corporation:  Form 10 filed on June 2,
2011, file number 000-54427.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

     Bluewood Acquisition Corporation:  Form 10 filed on November 8,
2011, file number 000-54542.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

     Rosewood Acquisition Corporation:  Form 10 filed on November 8,
2011, file number 000-54544.  During the period of time covered by
this Report, Mr. Cassidy and Mr. McKillop were both directors
of the corporation and served as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop were the only shareholders
and each was indirect beneficial owner of 10,000,000 shares.  Rosewood
effected a change in control subsequent to the period of time covered
by this Report and filed a Form 8-K with the Securities and Exchange
Commisison reporting the change in control.

     Silverwood Acquisition Corporation:  Form 10 filed on November 8,
2011, file number 000-54545.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

     Yellowwood Acquisition Corporation:  Form 10 filed on November 8,
2011, file number 000-54546.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

Additional companies with which Messrs. Cassidy and McKillop are involved
created subsequent to the period covered by this report:

      Bentwood Acquisition Corporation:  Form 10 filed on January 27,
2012, file number 000-54590.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

      Hardwood Acquisition Corporation:  Form 10 filed on January 27,
2012, file number 000-54591.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

      Lightwood Acquisition Corporation:  Form 10 filed on January 27,
2012, file number 000-54592.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

      Roundwood Acquisition Corporation:  Form 10 filed on January 27,
2012, file number 000-54593.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

      Timberwood Acquisition Corporation:  Form 10 filed on January 27,
2012, file number 000-54594.  Mr. Cassidy and Mr. McKillop are both
directors of the corporation and serve as president and vice president,
respectively, Mr. Cassidy and Mr. McKillop are the only shareholders
and each is indirect beneficial owner of 10,000,000 shares.

Conflicts of Interest

    At December 31, 2011, the officers and directors of the Company
organized and expected to organize other companies of a similar nature
and with a similar purpose. Consequently, there potential inherent
conflicts of interest were possible.  In addition, insofar as either
Mr. Cassidy or Mr. McKillop may be engaged in other business
activities, they devoted only a portion of time to the affairs of
the Company.

     A conflict may arise with these listed blank check companies which
also seek target companies.  It is anticipated that target companies will
be located for the Company and other blank check companies in chronological
order of the date of filing of the Form 10 registration statement of such
blank check companies with the Securities and Exchange Commission or,
in the case of blank check companies with the same filing date,
alphabetically.

     Mr. Cassidy is the president, sole director and shareholder of
Tiber Creek Corporation, which is a shareholder of the Company.  At the
time of the change in control, some or all of the shares of common stock
owned by Tiber Creek Corporation may be retired by the Company.

     Mr. McKillop is the manager and sole member of MB Americus
LLC which is a shareholder of the Company.  At the time of a change in
control of the Company, some or all of the shares of common stock owned
by MB Americus LLC  may be purchased or retired by the Company.

     There are no binding guidelines or procedures for resolving
potential conflicts of interest. Failure by management to resolve
conflicts of interest in favor of the Company could result in
liability of management to the Company.  However, any attempt by
shareholders to enforce a liability of management to the Company
would most likely be prohibitively expensive and time consuming.

	Code of Ethics.  The Company has not at this time adopted a
Code of Ethics pursuant to rules described in Regulation S-K.  At
December 31, 2011, the Company had two persons who were the only
shareholders and who served as the directors and officers.

	The Company has no operations or business and does not receive
any revenues or investment capital.  The adoption of an Ethical Code
during the period covered by this report would not serve the primary
purpose of such a code to provide a manner of conduct as the development,
execution and enforcement of such a code would be by the same persons
and only persons to whom such code applied.  Furthermore, because the
Company does not have any activities, there are activities or transactions
which would be subject to this code.  At the time the Company enters
into a business combination or other corporate transaction, the current
officers and directors will recommend to any new management that such a
code be adopted.  The Company does not maintain an Internet website on
which to post a code of ethics.

	Corporate Governance.  For reasons similar to those described
above, the Company did not have a nominating nor audit committee of the
board of directors for the period covered by this Report.  At December
31, 2011, the Company consists of two shareholders who served as the
corporate directors and officers. The Company has no activities, and
receives no revenues.  At such time that the Company enters
into a business combination and/or has additional shareholders and a larger
board of directors and commences activities, the Company will propose
creating committees of its board of directors, including both a nominating
and an audit committee.  Because there are only two shareholders of the
Company, there is no established process by which shareholders to the
Company can nominate members to the Company's board of directors.
Similarly, however, at such time as the Company has more shareholders and
an expanded board of directors, the new management of the Company may
review and implement, as necessary, procedures for shareholder nomination
of members to the Company's board of directors.


Item 11.  Executive Compensation

     The Company's officerS and directorS do not receive any
compensation for services rendered to the Company, nor haVe they
received such compensation in the past.  The officers and directors
are not accruing any compensation pursuant to any agreement with the
Company.

     No retirement, pension, profit sharing, stock option or
insurance programs or other similar programs have been adopted by
the Company for the benefit of its employees.

     The Company does not have a compensation committee for
the same reasons as described above.


Item 12.  Security Ownership of Certain Beneficial Owners and
          Management and Related Stockholder Matters

     The following table sets forth, as of December 31, 2011, each
person known by the Company to be the beneficial owner of five
percent or more of the Company's common stock and the director and
officer of the Company.  The Company does not have any compensation
plans and has not authorized any securities for future issuance.
Except as noted, the holder thereof has sole voting and investment
power with respect to the shares shown.

Name and Address              Amount of Beneficial     Percent of
of Beneficial Owner               Ownership          Outstanding Stock

James M. Cassidy (1)                 10,000,000 (3)           50%
215 Apolena Avenue
Newport Beach, CA 92662

James K. McKillop (2)                10,000,000 (3)           50%
9454 Wilshire Boulevard
Beverly Hills, California 90212

All Executive Officers and           20,000,000              100%
Directors as a Group (2 Persons)

     (1) As the sole shareholder, officer and director of Tiber Creek
Corporation, a Delaware corporation, Mr. Cassidy is deemed to be the
beneficial owner of the shares of common stock of the Company owned by
it.

     (2) As the sole principal of MB Americus LLC, a California business
entity, Mr. McKillop is deemed to be the beneficial owner of the shares
of the Company owned by it.

    (3)  Of the 10,000,000 issued, 9,750,000 were redeemed as part of
the change in control in February, 2012, and an additional 1,000,000
shares were issued.


Item 13.  Certain Relationships and Related Transactions and
	  Director Independence

   At December 31, 2011, the Company had issued a total of 20,000,000
shares of common stock pursuant to Section 4(2) of the Securities Act
for a total of $2,000 in cash.

    James M. Cassidy was the president and a director of the Company
at December 31, 2011, and the sole officer, director and the shareholder
of Tiber Creek Corporation, then a 50% shareholder of the Company.

     James McKillop was vice president and a director of the Company and
the sole manager and member of MB Americus LLC, then a 50% shareholder
of the Company.

    As the organizers and developers of the Company, James M. Cassidy and
James McKillop may be  considered promoters.  Mr. Cassidy has provided
services to the Company without charge consisting of preparing and filing
the charter corporate documents and preparing this registration statement.
Tiber Creek Corporation, a company of which Mr. Cassidy is the sole
director, officer and shareholder, has paid expenses incurred by the Company
without repayment.  Tiber Creek is a shareholder of the Company
and may receive benefits in the future if the Company is able to effect
a business combination beneficial to the Company.

   The Company is not currently required to maintain an independent director
as defined by Rule 4200 of the Nasdaq Capital Market nor does it
anticipate that it will be applying for listing of its securities on an
exchange in which an independent directorship is required. It is likely
that neither Mr. Cassidy nor Mr. McKillop would not be considered
independent directors if it were to do so.


Item 14.  Principal Accounting Fees and Services.

	The Company has no activities, no income and no expenses
except for independent audit and Delaware state fees. The Company's
president has donated his time in preparation and filing of all
state and federal required taxes and reports.


Audit Fees

        The aggregate fees incurred for each of the last two years for
professional services rendered by the independent registered public
accounting firm for the audits of the Company's annual financial
statements and review of financial statements included in the Company's
Form 10-K and Form 10-Q reports and services normally provided in
connection with statutory and regulatory filings or engagements were
as follows:

                         December 31, 2011
	                 -----------------


                            =======
Audit-Related Fees          $ 750


	The Company does not currently have an audit committee serving
and as a result its board of directors performs the duties of an audit
committee.  The board of directors will evaluate and approve in advance,
the scope and cost of the engagement of an auditor before the auditor
renders audit and non-audit services.  The Company does not rely on pre-
approval policies and procedures.



                        PART IV


Item 15.  Exhibits, Financial Statement Schedules

	There are no financial statement schedules nor exhibits filed
herewith.  The exhibits filed in earlier reports and the Company's
Form 10 are incorporated herein by reference.

<PAGE>










FINANCIAL STATEMENTS




Report of Independent Registered Public Accounting Firm	            1

Balance Sheet as of December 31, 2011                               2

Statement of Operations for the period from September 21, 2011
 (Inception) to December 31, 2011	                            3

Statement of Changes in Stockholders' Equity for the Period
 from September 21, 2011 (Inception) to December 31, 2011           4


Statement of Cash Flows for the period from September 21, 2011
 (Inception) to December 31, 2011                                   5

Notes to Financial Statements 	                                   6-9


<PAGE>


ANTON & CHIA, LLP                      CERTIFIED PUBLIC ACCOUNTANTS

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors
American Laser Healthcare Corporation
(A Development Stage Company)

We have audited the accompanying balance sheet of American Laser
Healthcare Corporation formerly known as Amberwood Acquisition
Corporation (the "Company") as of December 31, 2011, and the related
statements of operations, stockholders' equity and cash flows for the
period from September 21, 2011 (Inception) through December 31, 2011.
These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these
financial statements based on our audit.

We conducted our audits in accordance with standards of the Public
Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audits to obtain reasonable assurance
about whether the financial statements are free of material misstatement.
The Company was not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. Our audit included
consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but
not for the purpose of expressing an opinion on the effectiveness of
Company's internal control over financial reporting. Accordingly, we
express no such opinion. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements.
An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of the Company as of
December 31, 2011 and the results of its operations and its cash flows for
the period from September 21, 2011 (Inception) through December 31, 2011,
in conformity with accounting principles generally accepted in the United
States of America.

The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 2 to the
financial statements, the Company has had no revenues and income since
inception.  Management's plans concerning these matters are also described
in Note 2, which includes the raising of additional equity financing or
merger with another entity. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.


/s/ Anton & Chia, LLP
Newport Beach, CA
March 28, 2012



<PAGE>




                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                               BALANCE SHEETS
                            As of December 31, 2011


                       ASSETS


                                                    December 31,
                                                        2011
                                                 -----------------

  Current Assets
    Cash                                         $         2,000
                                                 -----------------
                       Total Assets              $         2,000
                                                 =================

             LIABILITIES AND STOCKHOLDERS' EQUITY

  Current Liabilities
    Accounts payable and accrued liabilities     $           400
                                                 -----------------
            Total Liabilities                    $           400
                                                 -----------------

  Stockholders' Equity
    Preferred stock, $0.0001 par value,          $            -
    20,000,000 shares authorized; none
    outstanding
    Common Stock; $0.0001 par value,                       2,000
    100,000,000 shares authorized;
    20,000,000 shares issued and
    outstanding
  Additional paid-in capital                                 943
  Deficit accumulated during the
    development stage                                     (1,343)
                                                 -----------------
          Total Stockholders' Equity             $         1,600
                                                 -----------------

          Total Liabilities and
          Stockholders' Equity                   $         2,000
                                                 =================


 The accompanying notes are an integral part of these financial statements

                                     2

<PAGE>


                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                         STATEMENTS OF OPERATIONS
                              For the Period
           from September 21, 2011 (Inception) to December 31, 2011

                                                  For the period from
                                                   September 21, 2011
                                                    (Inception) to
                                                      December 31,
                                                         2011
                                                 -----------------

    Operating expenses                           $          1,343
                                                 -----------------

    Net loss                                     $         (1,343)
                                                 =================


    Loss per share - basic and diluted           $         (0.00)
                                                 -----------------

    Weighted average shares-basic and diluted          20,000,000
                                                 -----------------




 The accompanying notes are an integral part of these financial statements

                                     3

<PAGE>


                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                 STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
   For the Period from September 21, 2011 (Inception) to December 31, 2011




<TABLE>
<CAPTION>
                                                                Deficit
                                                                Accumulated
                             Common Stock           Additional  During the    Total
                          -----------------------   Paid-In     Development   Stockholders'
                          Shares        Amount      Capital     Stage         Equity
<S>                       <C>           <C>         <C>         <C>           <C>

Balance, September 21,
  2011 (Inception)            -         $     -     $    -      $      -      $     -

Common stock issued       20,000,000      2,000          -             -         2,000

Additional paid-in
  capital                      -              -        943             -           943

Net loss                       -              -          -        (1,343)       (1,343)
                          ==========     =======    =======     =========      =========
Balance,
 December 31, 2011        20,000,000     $ 2,000    $  943      $ (1,343)      $ 1,600
                          ==========     =======    =======     =========      =========

</TABLE>



 The accompanying notes are an integral part of these financial statements

                                     4

<PAGE>


                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                          STATEMENT OF CASH FLOWS
                              For the Period
          from September 21, 2011 (Inception) to December 31, 2011


                                                 For the period from
                                                  September 21, 2011
                                                    (Inception) to
                                                  December 31, 2011
                                                 ------------------

OPERATING ACTIVITIES

   Net loss                                      $        (1,343)
                                                 ------------------

   Changes in Operating Assets and Liabilities
       Accrued liabilities                                   400
                                                 ------------------
       Cash used in operating activities                    (943)
                                                 ------------------
FINANCING ACTIVITIES

   Proceeds from issuance of common stock                  2,000
   Proceeds from stockholders' additional
       paid-in capital                                       943
                                                 ------------------
       Cash provided by financing activities               2,943
                                                 ------------------
   Net increase in cash                                    2,000

   Cash, beginning of period                                   -
                                                 ------------------
   Cash, end of period                            $        2,000
                                                 ==================


 The accompanying notes are an integral part of these financial statements

                                     5
<PAGE>

                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                     Notes to the Financial Statements

NOTE 1   NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT POLICIES

NATURE OF OPERATIONS

American Laser Healthcare Corporation, formerly known as Amberwood
Acquisition Corporation, ("the Company") was incorporated on
September 21, 2011 under the laws of the State of Delaware to engage in
any lawful corporate undertaking, including, but not limited to, selected
mergers and acquisitions. The Company has been in the developmental
stage since inception and its operations to date have been limited to
issuing shares to its original shareholders and filing this registration
statement. The Company will attempt to locate and negotiate with a
business entity for the combination of that target company with American
Laser Healthcare Corporation. The combination will normally take the
form of a merger, stock-for-stock exchange or stock-for-assets exchange.
In most instances the target company will wish to structure the business
combination to be within the definition of a tax-free reorganization under
Section 351 or Section 368 of the Internal Revenue Code of 1986, as
amended. No assurances can be given that the Company will be
successful in locating or negotiating with any target company. The
Company has been formed to provide a method for a foreign or domestic
private company to become a reporting company with a class of securities
registered under the Securities Exchange Act of 1934.

BASIS OF PRESENTATION

The summary of significant accounting policies presented below is
designed to assist in understanding the Company's financial statements.
Such financial statements and accompanying notes are the representations
of the Company's management, who are responsible for their integrity and
objectivity. These accounting policies conform to accounting principles
generally accepted in the United States of America ("GAAP") in all
material respects, and have been consistently applied in preparing the
accompanying financial statements.

USE OF ESTIMATES

The preparation of financial statements in conformity with GAAP
requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements, and the
reported amounts of revenues and expenses during the reporting periods.
Actual results could differ from those estimates.

CONCENTRATION OF RISK

Financial instruments that potentially subject the Company to
concentrations of credit risk consist principally of cash. The Company
places its cash with high quality banking institutions. From time to time,
the Company maintains cash balances at certain institutions in excess of
the Federal Deposit Insurance Corporation limit.

INCOME TAXES

Under ASC 740, "Income Taxes", deferred tax assets and liabilities are
recognized for the future tax consequences attributable to temporary
differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets
and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are
expected to be recovered or settled. Valuation allowances are established
when it is more likely than not that some or all of the deferred tax assets
will not be realized.

                                     6
<PAGE>

                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                     Notes to the Financial Statements

NOTE 1   NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT POLICIES
         (CONTINUED)

LOSS PER COMMON SHARE

Basic loss per common shares excludes dilution and is computed by
dividing net income by the weighted average number of common shares
outstanding during the period. Diluted loss per common share reflect the
potential dilution that could occur if securities or other contracts to
issue common stock were exercised or converted into common stock or
resulted in the issuance of common stock that then shared in the loss
of the entity.  As of December 31, 2011 there are no outstanding dilutive
securities.

FAIR VALUE OF FINANCIAL INSTRUMENTS

FASB ASC 820 "Fair Value Measurements and Disclosures" establishes a
three-tier fair value hierarchy, which prioritizes the inputs in measuring
fair value. The hierarchy prioritizes the inputs into three levels based
on the extent to which inputs used in measuring fair value are observable
in the market.

These tiers include:

      Level 1: defined as observable inputs such as quoted prices in
               active markets;
     Level 2:  defined as inputs other than quoted prices in active
               markets that are either directly or indirectly observable;
               and
     Level 3:  defined as unobservable inputs in which little or no
               market data exists, therefore requiring an entity to develop
               its own assumptions.

The carrying amounts of financial assets and liabilities, such as cash
and accrued liabilities approximate their fair values because of the short
maturity of these instruments.

Note 2 - GOING CONCERN

The Company has sustained net loss of $1,343 since inception of the
Company on September 21, 2011. Additionally, the Company has accumulated
deficit of $1,343 on December 31, 2011.  The Company's continuation as
a going concern is dependent on its ability to generate sufficient cash
flows from operations to meet its obligations, which it has not been
able to accomplish to date, and /or obtain additional financing
from its stockholders and/or other third parties.

These financial statements have been prepared on a going concern basis,
which implies the Company will continue to meet its obligations and
continue its operations for the next fiscal year. The continuation of the
Company as a going concern is dependent upon financial support from its
stockholders, the ability of the Company to obtain necessary equity
financing to continue operations, successfully locating and negotiate with
a business entity for the combination of that target company with the
Company.

The Company's management will pay all expenses incurred by the Company
without repayment until a business combination is effected.  There
is no assurance that the Company will ever be profitable. The
financial statements do not include any adjustments to reflect the
possible future effects on the recoverability and classification
of assets or the amounts and classifications of liabilities that
may result should the Company be unable to continue as a going
concern.

                                     7
<PAGE>

                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                     Notes to the Financial Statements

NOTE 3 - RECENT ACCOUNTING PRONOUNCEMENTS

Adopted

In January 2010, FASB issued ASU No. 2010-01- Accounting for
Distributions to Shareholders with Components of Stock and Cash. The
amendments in this update clarify that the stock portion of a distribution
to shareholders that allows them to elect to receive cash or stock with a
potential limitation on the total amount of cash that all shareholders can
elect to receive in the aggregate is considered a share issuance that is
reflected in EPS prospectively and is not a stock dividend for purposes of
applying Topics 505 and 260 (Equity and Earnings Per Share). The
amendments in this update are effective now. The adoption of this ASU
did not have a material impact on our financial statements.


In January 2010, FASB issued ASU No. 2010-06   Improving
Disclosures about Fair Value Measurements. This update provides
amendments to Subtopic 820-10 that requires new disclosure as follows:
1) Transfers in and out of Levels 1 and 2.  A reporting entity should
disclose separately the amounts of significant transfers in and out of
Level 1 and Level 2 fair value measurements and describe the reasons for
the transfers.  2)  Activity in Level 3 fair value measurements.  In the
reconciliation for fair value measurements using significant unobservable
inputs (Level 3), a reporting entity should present separately information
about purchases, sales, issuances, and settlements (that is, on a gross
basis rather than as one net number). This update provides amendments to
Subtopic 820-10 that clarifies existing disclosures as follows: 1) Level
of disaggregation. A reporting entity should provide fair value measurement
disclosures for each class of assets and liabilities. A class is often a
subset of assets or liabilities within a line item in the statement of
financial position. A reporting entity needs to use judgment in determining
the appropriate classes of assets and liabilities. 2) Disclosures about
inputs and valuation techniques. A reporting entity should provide
disclosures about the valuation techniques and inputs used to measure
fair value for both recurring and nonrecurring fair value measurements.
Those disclosures are required for fair value measurements that fall in
either Level 2 or Level 3. The new disclosures and clarifications of
existing disclosures are effective now. The adoption of the ASU's did
not have a material impact on the financial statements.

In December 2010, the FASB issued ASU 2010-29, which contains updated
accounting guidance to clarify the acquisition date that should be
used for reporting pro forma financial information when comparative
financial statements are issued.  This update requires that a company
should disclose revenue and earnings of the combined entity as though
the business combination(s) that occurred during the current year had
occurred as of the beginning of the comparable prior annual reporting
period only.  This update also requires disclosure of the nature and
amount of material, nonrecurring pro forma adjustments. The adoption
of this ASU did not have a material impact on our financial statements.

                                     8
<PAGE>

                    American Laser Healthcare Corporation
                 (formerly Amberwood Acquisition Corporation)
                       (A DEVELOPMENT STAGE COMPANY)
                     Notes to the Financial Statements



In September 2011, the Financial Accounting Standards Board ("FASB")
issued Accounting Standards Update ("ASU") 2011-08,
"Intangibles-Goodwill and Other (Topic 350): Testing Goodwill
Impairment" which is intended to simplify goodwill impairment testing
by permitting the assessment of qualitative factors to determine whether
events and circumstances lead to the conclusion that it is necessary to
perform the traditional two-step impairment test.  Under this update, we
are not required to calculate the fair value of our reporting units unless
we conclude that it is more likely than not (likelihood of more than 50%)
that the carrying value of our reporting units is greater than the fair
value of such units based on our assessment of events and circumstances.
This update is effective for fiscal years beginning after December 15,
2011, with early adoption permitted.  We have adopted the provisions
of this update at the beginning of our fourth quarter.  The adoption
of this provision did not have a material impact on our financial
statements.

Not Yet Adopted

In May 2011, the FASB issued ASU 2011-04, "Amendments to Achieve
Common Fair Value Measurement and Disclosure Requirements in U.S.
GAAP and International Financial Reporting Standards (IFRS) of Fair
Value Measurement   Topic 820."  ASU 2011-04 is intended to provide a
consistent definition of fair value and improve the comparability of fair
value measurements presented and disclosed in financial statements
prepared in accordance with U.S. GAAP and IFRS.  The amendments
include those that clarify the FASB's intent about the application of
existing fair value measurement and disclosure requirements, as well as
those that change a particular principle or requirement for measuring fair
value or for disclosing information about fair value measurements.  This
update is effective for annual and interim periods beginning after
December 15, 2011.The adoption of this ASU is not expected to have a
material impact on our financial statements.

NOTE 4   STOCKHOLDER'S EQUITY

On September 27, 2011, the Company issued 20,000,000 common shares
to two directors and officers for $2,000 in cash.

NOTE 5   SUBSEQUENT EVENTS

On February 23, 2012, the Company amended its certificate of
incorporation to change its name to BioLaser Technology Inc.

On March 16, 2012, the Company amended its certificate of
incorporation to change its name to American Laser Healthcare
Corporation.

On March 27, 2012, the following events occurred which resulted in
a change of control of the Company:

	1.  The Company redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001
per share for an aggregate redemption price of $1,950.

	2.   The then current officers and directors resigned.

	3.   New officers and directors were appointed and elected.

	On March 28, 2011 the Company issued 1,000,000 shares of its
common stock.

                                   9


<PAGE>

                  SIGNATURES


     Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto
duly authorized.

                              AMERICAN LASER HEALTHCARE CORPORATION



                              By:   /s/ James M. Cassidy
                                President Principal executive officer
				and Principal Financial Officer
				For the period covered by this Report
Dated:  April 9, 2012


     Pursuant to the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

NAME                          OFFICE              DATE

/s/ James M. Cassidy          Director            April 9, 2012
                              For the period
			      covered by this Report


<PAGE>